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ABSTRACT
Past researches indicate that some types of antibiotics, apart from their 
antimicrobial effects, have some other important effects which indir-
ectly are exerted by modulating and regulating the immune system’s 
mediators. Among the compounds with antimicrobial effects, fluoro-
quinolones (FQs) are known as synthetic antibiotics, which exhibit the 
property of decomposing of DNA and prevent bacterial growth by 
inactivating the enzymes involved in DNA twisting, including topoi-
somerase II (DNA gyrase) and IV. Interestingly, immune responses are 
indirectly modulated by FQs through suppressing pro-inflammatory 
cytokines, such as interleukin 1 (IL-1), IL-6, tumor necrosis factor-alpha 
(TNF-α), and super-inducing IL-2, which tend to increase both the 
growth and activity of T and B lymphocytes. In addition, they affect 
the development of immune responses by influencing of expression of 
other cytokines and mediators. This study aims to review past research 
on the immunomodulatory effects of FQs on the expression of cyto-







FQs are a broad range of synthetic antibiotics that are being widely consumed for their 
clinical features, including their availability, wide therapeutic index, and reasonable level of 
resistance (Mitscher 2005). These antimicrobial compounds exert their effects by entering 
into the cytosol of bacteria, binding to topoisomerase II (DNA gyrase) and IV, and 
inactivating these enzymes, especially in prokaryotes (Aldred et al. 2013). One of the 
distinctive features making FQs different from other natural antibiotics is their inherent 
physicochemical properties that help them to penetrate into the lipid bilayer of gram- 
negative bacteria to exert antimicrobial effects (Dalhoff and Schubert 2016; Idowu and 
Schweizer 2017). Given the broad range of antimicrobial activities, FQs are classified into 
four generations. The first generation includes oxolinic acid, inoxacin, flumequine, peflox-
acin, rosoxacin, and nalidixic acid; the second generation encompasses ciprofloxacin, 
fleroxacin, lomefloxacin, nadifloxacin, norfloxacin, ofloxacin, and rufloxacin; the third 
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